Graham A. Jenkin

246 Clayton Rd
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Cord blood-derived cell therapies for preterm brain injury.

Cord blood-derived cell therapies for preterm brain injury.

Journal: Early human development

Published: July 28, 2025

Umbilical Cord Blood Endothelial Progenitor Cells Modulate Neurovascular Unit Damage in a Neonatal Rat Model of Hypoxia Ischemia.

Umbilical Cord Blood Endothelial Progenitor Cells Modulate Neurovascular Unit Damage in a Neonatal Rat Model of Hypoxia Ischemia.

Journal: Stem cell reviews and reports

Published: July 06, 2025

Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy: Secondary Analysis of a Nonrandomized Clinical Trial.

Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy: Secondary Analysis of a Nonrandomized Clinical Trial.

Journal: JAMA network open

Published: July 03, 2025

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol.

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol.

Journal: BMJ open

Published: June 18, 2025

Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).

Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).

Journal: Pediatric research

Published: December 04, 2024

Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study).

Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study).

Journal: EBioMedicine

Published: August 02, 2024

Fetal growth restriction adversely impacts trajectory of hippocampal neurodevelopment and function.

Fetal growth restriction adversely impacts trajectory of hippocampal neurodevelopment and function.

Journal: Brain pathology (Zurich, Switzerland)

Published: July 13, 2024

The Temporal Relationship between Blood-Brain Barrier Integrity and Microglial Response following Neonatal Hypoxia Ischemia.

The Temporal Relationship between Blood-Brain Barrier Integrity and Microglial Response following Neonatal Hypoxia Ischemia.

Journal: Cells

Published: February 29, 2024

Phenotype of early-onset fetal growth restriction in sheep.

Phenotype of early-onset fetal growth restriction in sheep.

Journal: Frontiers in endocrinology

Published: January 23, 2024

Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.

Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.

Journal: Stem cell research & therapy

Published: January 07, 2024

Early administration of umbilical cord blood cells following brief high tidal volume ventilation in preterm sheep: a cautionary tale.

Early administration of umbilical cord blood cells following brief high tidal volume ventilation in preterm sheep: a cautionary tale.

Journal: Journal of neuroinflammation

Published: January 02, 2024

Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review.

Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review.

Journal: Clinical immunology communications

Published: October 31, 2023

Showing 1-12 of 114

Last Updated: 09/26/2026